On the stock market since 2004, it operates in the world of money and finance. It has 411 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
Clearly below the class average.
Clearly below the class average.
The stock has been running stronger than the market lately.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
Growth: Sales growth trails the sector average.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades 27% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 27% — still a thick cushion, though costs have been eating into it lately.
Over the last 12 months, company executives reported 91 buys and 22 sells. Management buying with its own money is usually read as a good sign.
It pays out $2.58 per share each year — regular cash for whoever holds the stock.
Over the last 3 years, sales fell about 0% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 5/100.
The growth engine is running at low revs right now. Report-card grade: 18/100.
On our five-subject report card, CNS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CNS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.